Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07184528 · ClinicalTrials.gov registry record · NA
PATCHVALVE: Endobronchial Valves Plus Blood Patch for Persistent Air Leaks
A NA study of Persistent Air Leaks, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07184528 is a NA study of Persistent Air Leaks that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07184528, a NA study of Persistent Air Leaks, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate the real-world safety and effectiveness of combining endobronchial valve (IBV) placement with endobronchial blood patching (EBP) for the treatment of persistent air leaks (PALs) in adult patients undergoing bronchoscopy. PALs are a challenging condition often associated with prolonged hospital stays, increased morbidity, and delayed recovery. The main questions this study aims to answer are: * Does the combination of endobronchial valve placement and endobronchial blood patching accelerate resolution of persistent air leaks? * What are the procedural outcomes, complications, and hospital-related metrics (e.g., chest tube duration, length of stay, and readmission rates) associated with this technique? Participants will: * Undergo standard-of-care bronchoscopy with identification of air leak source. * Receive intrabronchial instillation of autologous blood and tranexamic acid (TXA) followed by balloon occlusion and endobronchial valve placement. * Be followed for resolution of air leak and post-procedure outcomes through standard inpatient monitoring and data collection.
Conditions Studied
Interventions
- DEVICE Endobronchial Blood Patch
- DEVICE Spiration Valve System (SVS) Placement
Study Locations (1)
Massachusetts
- Beth Isreal Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2027-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07184528
The ClinicalTrials.gov registry entry for NCT07184528 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Persistent Air Leaks appearing as the primary indexed condition, and to 2 interventions - of which Endobronchial Blood Patch is the first listed.
NCT07184528 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07184528 about?
NCT07184528 is a clinical study titled "PATCHVALVE: Endobronchial Valves Plus Blood Patch for Persistent Air Leaks". The goal of this study is to evaluate the real-world safety and effectiveness of combining endobronchial valve (IBV) placement with endobronchial blood patching (EBP) for the treatment of persistent air leaks (PALs) in adult patients undergoing bronchoscopy. PALs are a challenging condition often as...
What is the current status of trial NCT07184528?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-07-01. Estimated completion is 2027-07-01.
What conditions does trial NCT07184528 study?
This clinical trial studies the following conditions: Persistent Air Leaks.
What interventions are being tested in trial NCT07184528?
The interventions under investigation include: Endobronchial Blood Patch (DEVICE), Spiration Valve System (SVS) Placement (DEVICE).
Who is sponsoring clinical trial NCT07184528?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07184528 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Persistent Air Leaks
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.